LAS VEGAS, Dec. 15, 2021 /PRNewswire/ -- DelveInsight's
Cardiac Ablation Devices Market Insights and
Forecast report provides the current and forecast
Cardiac Ablation Devices Market, upcoming innovation in the
devices, individual market shares, challenges, drivers and
barriers, market trends, and key competitors in the Cardiac
Ablation Devices Market.
Some of the salient features from the Cardiac Ablation
Devices Market report:
- As per DelveInsight analysis, in terms of revenue share,
North America is predicted to
register the fastest growth in the Cardiac Ablation Devices
market.
- Major pharma players working proactively in the Cardiac
Ablation Devices Market include Abbott Laboratories, Boston
Scientific Corporation, Avanos Medical, Inc., Auris Health, Inc.,
Olympus, CONMED Corporation, ERBE ELEKTROMEDIZIN GMBH,
AngioDynamics, Medtronic Inc., AtriCure, Inc., Biosense Webster,
Inc., Teleflex Incorporated, St. Jude Medical Inc., Lepu Medical
Technology (Beijing) Co., Ltd.,
MicroPort Scientific Corporation, and others.
- DelveInsight analyzes that Global Cardiac Ablation Devices
Market was valued at USD 2.00
billion in 2020, and is expected to grow at a substantial
CAGR of 12.78% during the forecast period from 2021
to 2026 and is anticipated to reach USD
4.12 billion by 2026.
- On June 22, 2021,
Medtronic had obtained expanded FDA approval for
Cryoablation Catheters. The device has been indicated for
the treatment of paroxysmal atrial fibrillation as an early rhythm
control strategy.
- On January 29, 2021,
the United States had cleared
Medtronic's DiamondTemp Ablation (DTA) system to treat
patients with recurrent, symptomatic paroxysmal atrial fibrillation
(AF) and who have been unresponsive to drug therapy.
To pick on the latest highlights related to Cardiac Ablation
Devices, get the snapshot of the key highlights entailed in the
Cardiac Ablation Devices Market report.
Cardiac Ablation Devices Overview
Cardiac Ablation Devices are devices that are used as a
minimally invasive option for the treatment of atrial fibrillation.
Ablation is routinely performed using radiofrequency (RF) and
cryoballoon (CB) catheters, with RF catheters being the most widely
used technology. Cardiac Ablation comprises energy for making
smaller scars in the heart tissue. It can be also used for the
treatment of atrial fibrillation, a type of irregular heartbeat.
Cardiac Ablation is a surgical technique that can correct cardiac
arrhythmias by scarring tiny regions of the heart. Cardiac
arrhythmias arise where there is a deficiency of the electrical
impulses that regulate the heartbeats. As a consequence, heartbeats
are irregular and can lead to stroke or heart failure if left
untreated, and are one of the main causes of death.
Interested in knowing about Cardiac Ablation Devices Market
growth by 2026? Click to get a snapshot of Cardiac Ablation
Devices Market Analysis
Cardiac Ablation Devices Market Insight
Geographically, the global Cardiac Ablation Devices market is
studied for North America,
Europe, Asia-Pacific, and the Rest of the World. In
terms of market share, North
America tends to dominate the global Cardiac Ablation
Devices market in the present scenario and is expected that it will
continue to dominate during the forecast period. However, the
domination exhibited by North
America will be conspicuously challenged by the European
market. This supremacy witnessed is attributed to the rising
prevalence of cardiovascular disorder, a growing number of cases of
atrial fibrillation, technological advancements in the field of
Cardiac Ablation, and already established key manufacturers in the
North American region. Also, there are great opportunities for
market penetration for European regions as the major companies
already have a grip in developed regions.
On June 23, 2021, FDA had
received expanded approval for Medtronic's Arctic Front
Family of Cardiac Cryoablation Catheters for the treatment of
recurrent symptomatic paroxysmal atrial fibrillation (AFib).
Also, several approvals of the Cardiac Ablation Devices such as on
January 27, 2020, Imricor Medical
Systems, Inc. had announced that it has received CE mark
approval for its Vision-MR Ablation Catheter and
Vision-MR Dispersive Electrode. Additionally, J&J's
Biosense had also received CE Mark for the QDOT MICRO
Ablation Catheter.
To know more why North America
is the leader in market growth for the Cardiac Ablation Devices
market, get a snapshot of the report Cardiac Ablation Devices
market
Cardiac Ablation Devices Market Dynamics
Due to the increase in the prevalence of cardiovascular
disorders, there will be a higher demand for Cardiac Ablation
Devices. Also, with favorable reimbursement policies,
the presence of many key players, technological benefits
such as being minimally invasive, promising long-term
survival, and a multimodal approach, positively
influence the overall Cardiac Ablation Devices market. Other
factors such as lower cost of radiofrequency ablation, and
ease of use will also support the growth of the Cardiac
Ablation Devices market globally. Further, growth in new
therapies, technological advancements, increasing geriatric
population, and penetration and acceptance, approval,
and launch of technologically advanced devices in the market
will assertively lead to a boost in the Cardiac Ablation Devices
market.
The market for Cardiac Ablation Devices had observed a period of
reduced growth owing to the outbreak of COVID-19. Owing to
the COVID-19 pandemic situation, various forms of elective
procedures were temporarily stopped in contrast to the COVID-19
affected patients that were given utmost priority. Apart from this,
several other factors including the lockdown-related
restrictions, patient reluctance to visit the hospitals and
clinics, logistical issues, and the temporary closing of
manufacturing companies had further affected the healthcare
system.
To get a deeper understanding of the driving factors related to
the Cardiac Ablation Devices market, find a snapshot of the
Cardiac Ablation Devices Market Dynamics.
Scope of the Cardiac Ablation Devices
Market Report
Study Period: 2018-2026
Key Companies: Abbott Laboratories, Boston Scientific
Corporation, Avanos Medical, Inc., Auris Health, Inc., Olympus,
CONMED Corporation, ERBE ELEKTROMEDIZIN GMBH, AngioDynamics,
Medtronic Inc., AtriCure, Inc., Biosense Webster, Inc., Teleflex
Incorporated, St. Jude Medical Inc., Lepu Medical Technology
(Beijing) Co., Ltd., MicroPort
Scientific Corporation, and others.
Cardiac Ablation Devices Market Segmentation
By Product
- Radiofrequency (RF) Ablation
-
- Temperature-Controlled Radiofrequency Ablators
- Fluid-Cooled Radiofrequency Ablators
- Robotic Catheter Manipulation Systems
- Electrical Ablation
-
- Argon Plasma/Beam Coagulators
- Irreversible Electroporation Systems
- Cryoablation
-
- Tissue Contact Probes
- Others
- Ultrasound Ablation
-
- High-Intensity Focused Ultrasound Ablators
- Ultrasound Ablation Systems
- Others
- Microwave Ablation
-
- Microwave Thermotherapy Devices
By Technology
- Radiofrequency (RF) Ablation
- Electrical Ablation
- Cryoablation
- Ultrasound Ablation
- Microwave Ablation
By Application
- Cardiac Rhythm Management
- Open Surgery
- Others
By End-User
- Hospitals
- Cardiac Centres
- Ambulatory Surgical Centers
By Geography
- North America
- Europe
- Asia-Pacific
- Rest of World
Delveinsight Analysis: The Cardiac Ablation Devices
market is expected to grow at a CAGR of 12.78% and will reach
USD 4.12 billion by 2026.
Table of Contents
1
|
Cardiac Ablation
Devices Market Report Introduction
|
2
|
Cardiac Ablation
Devices Market Executive summary
|
3
|
Regulatory and
Patent Analysis
|
4
|
Cardiac Ablation
Devices Market Key factors Analysis
|
5
|
Cardiac Ablation
Devices Porter's Five Forces Analysis
|
6
|
COVID-19 Impact
Analysis on Cardiac Ablation Devices Market
|
7
|
Cardiac Ablation
Devices Market Layout
|
8
|
Cardiac Ablation
Devices Global Company Share Analysis – Key 3-5
Companies
|
9
|
Cardiac Ablation
Devices Market Company and Product Profiles
|
|
9.1 Abbott
Laboratories
9.2 Boston
Scientific Corporation
9.3 Avanos
Medical, Inc.
9.4 Auris Health,
Inc.
9.5
Olympus
9.6 CONMED
Corporation
9.7 ERBE
ELEKTROMEDIZIN GMBH
9.8
AngioDynamics
9.9 Medtronic
Inc.
9.10 AtriCure,
Inc.
9.11 Biosense
Webster, Inc.
9.12 Teleflex
Incorporated
9.13 St. Jude
Medical Inc.
9.14 Lepu Medical
Technology (Beijing)Co., Ltd.
9.15 MicroPort
Scientific Corporation
|
10
|
Project
Approach
|
11
|
KOL
Views
|
12
|
About
DelveInsight
|
13
|
Disclaimer &
Contact Us
|
Learn more about the report offerings @ Cardiac
Ablation Devices Market Outlook
Understand the Competition, Risk Assessment, and
effective Research and Development approach to
take value-based decisions.
Related Reports
Cardiac Valvulotome Market
"DelveInsight's 'Cardiac Valvulotome - Market Insight,
Competitive Landscape and Market Forecast, 2026' report
delivers an in-depth understanding of Cardiac Valvulotome and the
historical and forecasted Cardiac Valvulotome market trends,
globally, which comprises of North
America, Europe, APAC, and
RoW, market drivers & barriers, unmet needs, and key companies
involved such as Braun Melsungen AG, LeMaitre Vascular, Inc.,
Andramed GmbH,BD., InvaMed, Koven Technology Canada Inc, and
others.
Cardiac Resynchronization Therapy Market
"DelveInsight's 'Cardiac Resynchronization Therapy - Market
Insight, Competitive Landscape and Market Forecast, 2026'
report delivers an in-depth understanding of Cardiac
Resynchronization Therapy and the historical and forecasted Cardiac
Resynchronization Therapy market trends, globally, which comprises
of North America, Europe, APAC, and RoW, market drivers &
barriers, unmet needs, and key companies involved such as Boston
Scientific Corporation, Medtronic, Medico S.p. A, Microport
Scientific Corporation, Biotronik, EBR Systems, Abbott, and
others.
Cardiac Restoration Systems Market
"DelveInsight's 'Cardiac Restoration Systems - Market
Insight, Competitive Landscape and Market Forecast, 2026'
report delivers an in-depth understanding of Cardiac Restoration
Systems and the historical and forecasted Cardiac Restoration
Systems market trends, globally, which comprises of North America, Europe, APAC, and RoW, market drivers &
barriers, unmet needs, and key companies involved such as
Abbott, BioVentrix,CryoLife, Edwards Lifesciences
Corporation,NeoChord, XELTIS, and others.
Cardiac Output Monitors Market
"DelveInsight's 'Cardiac Output Monitors - Market Insight,
Competitive Landscape and Market Forecast, 2026' report
delivers an in-depth understanding of Cardiac Output Monitors and
the historical and forecasted Cardiac Output Monitors market
trends, globally, which comprises of North America, Europe, APAC, and RoW, market drivers &
barriers, unmet needs, and key companies involved such as Osypka
Medical GmbH, CNSystems Medizintechnik GmbH., Uscom,Deltex Medical
Limited, Edward Lifesciences Corporation, ICU Medical, Inc., LiDCO,
Baxter., Getinge AB., GE Healthcare (GENERAL ELECTRIC COMPANY),
Biotronik, and others.
Cardiac Monitoring Devices Market
Global Cardiac Monitoring Devices Market report
delivers an in-depth understanding of Cardiac Monitoring Devices
and the historical and forecasted Cardiac Monitoring Devices market
trends, market drivers & barriers, unmet needs, and key
companies involved such as Medtronic, Boston Scientific, Abbott
Laboratories, GE Healthcare, BIOTRONIK, and Koninklijke Philips,
Asahi Kasei Corporation, MicroPort Scientific Corporation, Hill-Rom
Holdings, Nihon Kohden, SCHILLER AG, BioTelemetry, BPL Medical
Technologies, ACS Diagnostics, and others.
Cardiac Biomarkers Testing Market
Global Cardiac Biomarkers Testing Market was valued at
USD 3.25 billion in 2020, growing at
a CAGR of 7.76% during the forecast period from 2021 to 2026 to
reach USD 5.07 billion by 2026. The
report delivers an in-depth understanding of Global Cardiac
Biomarkers Testing and the historical and forecasted Global Cardiac
Biomarkers Testing market trends, market drivers & barriers,
unmet needs, and key companies involved such as Beckman Coulter, Siemens Healthcare GmbH,
Abbott, bioMérieux SA, F. Hoffmann-La Roche Ltd, Thermo Fischer
Scientific Inc, Bio-Rad Laboratories Inc, Eurolyser Diagnostica
GmbH, Diagnostic Automation / Cortez Diagnostics, Randox
Laboratories Ltd, Tosoh Corporation, DIALAB GmbH, CardioGenics
Holdings Inc, and others.
Cardiac Assist Devices Market
Global Cardiac Assist Devices Market was valued at
USD 2.55 billion in 2020, growing at
a CAGR of 13.70% during the forecast period from 2021 to 2026, to
reach USD 5.50 billion by 2026. The
report delivers an in-depth understanding of Global Cardiac Assist
Devices and the historical and forecasted Global Cardiac Assist
Devices market trends, market drivers & barriers, unmet needs,
and key companies involved such as Abbott Laboratories, Teleflex
Incorporated, SynCardia Systems, LLC, St. Jude Medical Inc, CARMAT,
CorWave SA, Medtronic PLC, Terumo Heart, NovaPump GmbH, Getinge AB
Balton Ltd, Meril Life Sciences Pvt. Ltd, Thoratec Corporation,
and others.
3D Cardiac Mapping System Market
"DelveInsight's '3D Cardiac Mapping System - Market Insight,
Competitive Landscape and Market Forecast, 2026' report
delivers an in-depth understanding of 3D Cardiac Mapping System and
the historical and forecasted 3D Cardiac Mapping System market
trends, globally, which comprises of North America, Europe, APAC, and RoW, market drivers &
barriers, unmet needs, and key companies involved such as
Biosense Webster, (Jhonson & Jhonson), Boston Scientific
Corporation, Abbott, Kardium, Medtronic, Catheter Robotics, Inc,
Lepu Medical, EP Solutions SA, and others.
Browse Through Our Blog Posts
- Medical Devices Market Blooms as the Key MedTech
Companies Continue to Bring-In Innovation
- With advancements in Innovative Technology, Cardiac
Monitoring Devices Market is Booming
Significantly
- Mapping the Increasing Burden of Heart Failure: What
Does it Bring for Healthcare Market Companies?
- What Factors are Shaping the Trends in
the Implantable Cardiac Monitors
Market?
Connect With Us at LinkedIn | Facebook
| Twitter
Contact Us
Shruti Thakur
info@delveinsight.com
+1(919)321-6187
www.delveinsight.com
View original
content:https://www.prnewswire.com/news-releases/cardiac-ablation-devices-market-is-anticipated-to-surge-at-a-cagr-of-12-78-and-is-also-contemplated-to-reach-usd-4-12-billion-by-2026--analyzes-delveinsight-301445210.html
SOURCE DelveInsight Business Research, LLP